Clinical Trials Logo

Clinical Trial Summary

An adequate fiber intake is crucial for a well-balanced diet and reduces the risk of chronic diseases. However, nutritional recommendations for chronic kidney disease patients lead to an insufficient fiber intake with possible maladaptive effects on the gut microbiome. Therefore, we want to study the effects of a 35-day inulin supplementation on the gut microbiome, gut barrier function, bacterial metabolites and immune cell states in chronic kidney disease patients.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05071131
Study type Interventional
Source Charite University, Berlin, Germany
Contact Victoria McParland, PhD
Phone +49 30 450 540 464
Email victoria.mcparland@charite.de
Status Recruiting
Phase N/A
Start date February 1, 2022
Completion date February 1, 2027

See also
  Status Clinical Trial Phase
Completed NCT05465863 - Humoral and Cellular İmmune Response to SARS-CoV-2 mRNA BNT162b2 Vaccine in Children With Chronic Kidney Diseases N/A
Recruiting NCT06126016 - A Observational Study to Evaluate the Efficacy and Safety of Pacitol Inj.
Not yet recruiting NCT05234047 - Study Evaluating Denosumab on Vascular and Bone Metabolism in Osteoporotic Chronic Kidney Disease (HDENOBS)
Completed NCT04805632 - Immune Response in Dialysis Patients Vaccinated Against COVID-19
Completed NCT05729126 - The Discrepancy in Radiologists' Practice of Intravenous Contrast Imaging Studies Among Chronic Kidney Disease Patients
Recruiting NCT05549154 - A Study on Prevention Strategies for CKD-SHPT and Related Complications Based on General Vitamin D Supplementation N/A
Recruiting NCT05805813 - Cross-control Study on the Effect of Peritoneal Rest on Peritoneal Transport Function in Peritoneal Dialysis Patients N/A
Recruiting NCT05339009 - Bio-ADM as a Biomarker of Refilling in Chronic Hemodialysis Patient